These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13884582)

  • 21. Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.
    Starke A; Imamura T; Unger RH
    J Clin Invest; 1987 Jan; 79(1):20-4. PubMed ID: 2878938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum inorganic phosphorus response to insulin in normal, pancreatectomized and alloxanized dogs].
    De Venanzi F; Carnevali T; Peña F
    Acta Cient Venez; 1966; 17(6):173-6. PubMed ID: 5967074
    [No Abstract]   [Full Text] [Related]  

  • 23. Morphine-induced hyperglycemia: role of insulin and glucagon.
    Ipp E; Schusdziarra V; Harris V; Unger RH
    Endocrinology; 1980 Aug; 107(2):461-3. PubMed ID: 6993188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of beta-selective blockade on levels of glucagon in blood plasma during insulin-induced hypoglycemia].
    Szelachowska M; Kinalska I
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):488-91. PubMed ID: 2702337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some observations on the effect of small doses of glucagon in normal and diabetic subjects.
    BUTTERFIELD WJ; FRY IK; WHICHELOW MJ
    Guys Hosp Rep; 1960; 109():95-109. PubMed ID: 13806530
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats.
    López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I
    Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Paradoxical hyperglucagonemia after oral administration of glucose in diabetic dogs. Impact of the cholinergic nervous system].
    Hillaire-Buys D; Ribes G; Gross R; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1987; 181(6):677-82. PubMed ID: 2970286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute lymphocyte count and serum inorganic phosphorus after glucose administration in diabetic patients.
    LAZARUS SS; VOLK BW; JACOBI M; GILADY MY
    Am J Clin Pathol; 1952 Feb; 22(2):127-34. PubMed ID: 14902711
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amethod for measuring deviations from equilibrium of the glucose anomers in blood.
    Hill JB
    J Appl Physiol; 1965 Jul; 20(4):749-54. PubMed ID: 5838726
    [No Abstract]   [Full Text] [Related]  

  • 32. The response of serum inorganic phosphorus and potassium to oral glucose in normal individuals and in patients with mild diabetes.
    RUNYAN JW; KANTOR N
    J Lab Clin Med; 1954 Sep; 44(3):400-2. PubMed ID: 13201847
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathologic effects of large amounts of glucagon.
    SALTER JM; DAVIDSON IW; BEST CH
    Diabetes; 1957; 6(3):248-52; discussion, 252-5. PubMed ID: 13427630
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats.
    Pedersen C; Porsgaard T; Thomsen M; Rosenkilde MM; Roed NK
    PLoS One; 2018; 13(3):e0194468. PubMed ID: 29558502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-induced hypocalcemia.
    Paloyan E; Paloyan D; Harper PV
    Metabolism; 1967 Jan; 16(1):35-9. PubMed ID: 6016820
    [No Abstract]   [Full Text] [Related]  

  • 36. [RECENT INFORMATION ON GLUCAGON].
    ABE M
    Naika; 1964 Apr; 13():622-8. PubMed ID: 14151342
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of N1-sulfanilylo-N2-n-butylcarbamide on course of alloxan diabetes in rabbits and on hyperglycemic factor (glucagon) in pancreatic extracts in dogs].
    CZYZYK A
    Pol Arch Med Wewn; 1957; 27(8):1057-67. PubMed ID: 13505313
    [No Abstract]   [Full Text] [Related]  

  • 38. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucagon and insulin on lipolysis and ketogenesis in sheep.
    Brockman RP
    Can J Comp Med; 1976 Apr; 40(2):166-70. PubMed ID: 1000386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hypophosphatemia associated with diabetes mellitus in six dogs and one cat.
    Willard MD; Zerbe CA; Schall WD; Johnson C; Crow SE; Jones R
    J Am Vet Med Assoc; 1987 Apr; 190(8):1007-10. PubMed ID: 3570950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.